Zevra Therapeutics (ZVRA) Minority Interest (2014 - 2015)

Zevra Therapeutics (ZVRA) posted Minority Interest of $28.2 million for Q1 2015, up 16.54% on a QoQ basis from $24.2 million in Q4 2014.

Zevra Therapeutics (ZVRA) Minority Interest (2014 - 2015) Analysis & Trends

Zevra Therapeutics' Minority Interest history runs 2 years deep, the most recent figure standing at $28.2 million for Q1 2015.

Quarterly Minority Interest changed N/A year-over-year to $28.2 million in Q1 2015, while the trailing twelve-month figure through Mar 2015 was $28.2 million (changed N/A YoY) and the FY2014 annual result came in at $24.2 million, changed N/A from the prior year.
Minority Interest was $28.2 million for Q1 2015 at Zevra Therapeutics, up from $24.2 million in the prior quarter.
Across five years, Minority Interest topped out at $28.2 million in Q1 2015 and bottomed at $24.2 million in Q4 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Zevra Therapeutics	239.71 Mn	39.10 Mn	34.32 Mn

Download Data

Date	Value
Mar 31, 2015	28.21 Mn
Dec 31, 2014	24.21 Mn